XML 40 R25.htm IDEA: XBRL DOCUMENT v3.22.1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value
The following table summarizes the types of assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy:
 March 31, 2022December 31, 2021
(in millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:        
Available-for-sale debt securities:
U.S. treasury securities$476 $— $— $476 $407 $— $— $407 
U.S. government agencies securities— — — — 
Non-U.S. government securities— 30 — 30 — 50 — 50 
Certificates of deposit— 153 — 153 — 249 — 249 
Corporate debt securities— 1,442 — 1,442 — 1,363 — 1,363 
Residential mortgage and asset-backed securities— 407 — 407 — 424 — 424 
Equity securities:
Money market funds2,360 — — 2,360 3,661 — — 3,661 
Equity investment in Galapagos NV (“Galapagos”)1,046 — — 1,046 931 — — 931 
Equity investment in Arcus Biosciences, Inc. (“Arcus”)436 — — 436 559 — — 559 
Other publicly traded equity securities243 — — 243 331 — — 331 
Deferred compensation plan253 — — 253 261 — — 261 
Foreign currency derivative contracts— 84 — 84 — 80 — 80 
Total$4,813 $2,122 $— $6,935 $6,150 $2,170 $— $8,320 
Liabilities:        
Liability for MYR GmbH (“MYR”) contingent consideration$— $— $322 $322 $— $— $317 $317 
Deferred compensation plan253 — — 253 261 — — 261 
Foreign currency derivative contracts— 11 — 11 — — 
Total$253 $11 $322 $586 $261 $$317 $583 
Summary of Change in Fair Value of Contingent Consideration
The following table summarizes the change in fair value of our contingent consideration:
Three Months Ended
March 31,
(in millions)20222021
Beginning balance$317 $— 
Additions— 341
Changes in valuation assumptions10 — 
Effect of foreign exchange remeasurement (6)— 
Ending balance
$322 $341